Markt Update 21/11/2013

De Amsterdamse effectenbeurs is vanmorgen in de min begonnen.

Ook de andere aandelenbeurzen in Europa openden lager nadat gisteravond bleek uit de notulen van de Federal Reserve dat de Amerikaanse centrale bank overweegt om in de komende maanden te beginnen met de afbouw van het stimuleringsbeleid.

De Amsterdamse index noteerde na enige minuten handelen 0,7 procent in de min op 393,94 punten. De MidKap verloor 0,4 procent tot 608,57 punten. De beurzen in Frankfurt, Parijs en Londen verloren tot 0,9 procent.

Grootste verliezer in de Amsterdamse index was vastgoedconcern Unibail-Rodamco met een min van ruim 1 procent. Verzekeraar Aegon was de enige winnaaar met een kleine winst van 0,2 procent.

In de MidKap stond biotechnologiebedrijf Pharming laatste met een verlies van meer dan 2 procent. Vastgoedinvesteerder NSI was de grootste winnaar met een plus van 1,5 procent.

Bron: IG

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

Find articles by analysts

Een artikel zoeken

Form has failed to submit. Please contact IG directly.